Abstract
The role of triple therapy, with inhaled corticosteroids (ICS), long-acting beta2 agonists (LABA) and long-acting muscarinic antagonists (LAMA), in the treatment of symptomatic patients with advanc...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
Paper Title
Journal
Date
